Adrenocortical carcinoma risk factors

Revision as of 18:36, 18 September 2017 by Medhat (talk | contribs)
Jump to navigation Jump to search

Adrenocortical carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenocortical carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

CT

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation Therapy

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Adrenocortical carcinoma risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenocortical carcinoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenocortical carcinoma risk factors

CDC on Adrenocortical carcinoma risk factors

Adrenocortical carcinoma risk factors in the news

Blogs on Adrenocortical carcinoma risk factors

Hospitals Treating Adrenocortical carcinoma

Risk calculators and risk factors for Adrenocortical carcinoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

The most potent risk factors in the development of adrenocortical cancer are TP53 mutation, Beckwith-Wiedemann syndrome and Carney complex.[1]

Risk Factors

Risk factor associated with adrenocortical carcinoma are:

Differential Diagnosis Gene mutations Clinical picture
Lynch syndrome
  • MSH2, MSH6, MLH1, PMS2
  • Colorectal cancer
  • Endometrial cancer
  • Sebaceous neoplasms
  • Ovarian cancer
  • Pancreatic cancer
  • Brain cancer
Neurofibromatosis

type 1

  • NF1
  • Malignant peripheral nerve sheet tumor
  • Pheochromocytoma
  • Café au lait spots
  • Neurofibroma
  • Optic glioma
  • Lisch nodule
  • Skeletal abnormalities
MEN1 45
  • MENIN
  • Foregut neuroendocrine tumors
  • Pituitary tumors
  • Parathyroid hyperplasia
  • Collagenoma
  • Angiofibroma
  • Adrenal adenoma/hyperplasia
Carney complex
  • PRKAR1A
  • Primary pigmented nodular
  • Adrenal disease
  • Large-cell calcifying Sertoli cell tumors
  • Thyroid adenoma
  • Myxoma
  • Somatotroph pituitary adenoma
BWS 41
  • IGF2, CDKN1C, H19
  • Wilms’ tumor
  • Hepatoblastoma
  • Macrosomia
  • Adrenocortical cytomegaly
  • Adrenal adenoma
  • Adrenal cyst
  • Hemihypertrophy
  • Macroglossia
  • Omphalocele

References

  1. National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq#section/_1

Template:WH Template:WS